Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Dimethaid Research seeks approval of Pennsaid via mutual recognition procedure

May 11, 2001

Binding, functional and immunological activity described for HS-378 in Noordwijkerhout

May 11, 2001

New series from Ajinomoto with utility in inflammation, cancer, etc.

May 9, 2001

Aventis warns of potential liver injury on Arava

May 9, 2001

Boehringer Ingelheim presents new cathepsin inhibitors in recent patent

May 7, 2001

Iomed's phase III trial for ProDex does not reach primary endpoint

May 7, 2001

Nitrile cathepsin S inhibitors in the AxyS pipeline

May 4, 2001

Promising profile emerges from phase Ib trial of oral p38 kinase inhibitor; phase II planned

May 3, 2001

Promising results emerge from phase III trial of Pennsaid

May 2, 2001

1,2,3-Thiadiazole COX-2 inhibitors designed at Merck Frosst

April 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...